History of the clinical use of umbilical cord blood hematopoietic cells

Cytotherapy

Volumn 7, Issue 3, 2005, Pages 219-227

  Gluckman, E ^a   Rocha, V ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Allogeneic; Cord blood; Hematopoietic stem cells; Transplant

Indexed keywords

CD34 ANTIGEN; CYTOKINE; HLA ANTIGEN; LYMPHOCYTE ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL COUNT; CELL MATURATION; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HEALTH CARE FACILITY; HISTORY OF MEDICINE; HLA MATCHING; HUMAN; ORGAN DONOR; PRENATAL DIAGNOSIS; PROGNOSIS; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 22944488913     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240510027136     Document Type: Article

References (57)

1. Auerbach AD, Liu O, Ghosh R et al. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia. Transfusion 1990;30:682-7.
2. Broxmeyer HE, Gordon GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-32.
3. Gluckman E, Devergie A, Schaison G et al. Bone marrow transplantation in Fanconi anemia. Br J Haematol 1980;45:557-64.
4. Berger R, Bernheim A, Gluckman E et al. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anemia patients. Br J Haematol 1980;45:565-8.
5. Gluckman E, Devergie A, Dutreix J. Radio sensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983;54:431-40.
6. Linch DC, Knott LJ, Rodeck CH, Huehns CH. Studies of circulating hematopoietic progenitor cells in human fetal blood. Blood 1982;59:976-82.
7. Hann IM, Bodger MP, Hoffbrand AV. Development of pluripotent hematopoietic progenitor cells in human fetuses. Blood 1983;62:118-23.
8. Forestier F, Daffos F, Catherine N et al. Developmental hematopoiesis in normal human fetal blood. Blood 1991;77:2360-3.
9. Harrison MR, Crombleholme TM, Tarantal AF et al. In utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet 1989;ii:1425-7.
10. Gale RP. Fetal liver transplantation in man in fetal liver transplantation. Current concepts and future directions. In: Lucarelli G, Fliedner TM, Gale RP, eds. Excerpta Medica International Congress Series 514, 1980:268-75.
11. Broxmeyer HE, Gluckman E, Auerbach A et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J cell Cloning 1990;8:76-91.
12. Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992;89:4109-13.
13. Burgio GR, Gluckman E, Locatelli F. Ethical reappraisal of 15 years of cord blood transplantation. Lancet 2003;361:250-2.
14. Gluckman E, O'Reilly R, Wagner J, Rubinstein P. Patents versus transplants. Nature 1996;382:108.
15. Gluckman E, Broxmeyer HE, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8.
16. Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling cord blood transplantation in forty four children with malignant and non malignant disease. Lancet 1995;346:214-9.
17. Linch DC, Brent L. Can cord blood be used? Nature 1989;340:676.
18. Nathan DG. The beneficence of neonatal hematopoiesis. N Engl J Med 1982;321:1190.
19. + cells. Blood 1989;74:1287-94.
20. + Cells in the human neonate. J Immunol 1990;145: 102-8.
21. Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitors cells from human umbilical cord blood. Blood 1994;83:2410-7.
22. Vaziri H, Dragowska W, Allsop RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-60.
23. Morrison SJ, Wandycz AM, Akashi K et al. The aging of hematopoietic stem cells. Nature Med 1996;2:1011-6.
24. Petit T, Dommergues M, Socié G et al. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele specific PCR amplification. Br J Haematol 1997;98:767-71.
25. Griffiths-Chu S, Patterson JAK, Berger CL et al. Characterization of immature T cell subpopulations in neonatal blood. Blood 1984;64:296-300.
26. Durandy A, Thuillier L, Forveille M, Fischer A. Phenotypic and functional characteristics of human newborns B lymphocytes. J Immunol 1990;144:60-5.
27. Harris DT, Schumacher MJ, Locascio J et al. Phenotypic and functional immaturity of human umbilical cord blood lymphocytes. Proc Natl Acad Sci USA 1992;89:1006-10.
28. McDouall RM, Suitters AJ, Smith H et al. Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol 1994;95:519-24.
29. Madrigal JA, Cohen SBA, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft versus host disease? It takes more than two to tango. Human Immunol 1997;56:1-5.
30. De La Selle V, Gluckman E, Bruley-Rosset M. Newborn blood can engraft adult mice without inducing graft versus host disease across non H-2 antigens. Blood 1996;87:3977-83.
31. De La Selle V, Gluckman E, Bruley-Rosset M. Graft versus host disease and graft versus leukemia effect in mice grafted with newborn blood. Blood 1998;15:3968-75.
32. Rocha V, Wagner JE, Sobocinski K et al. Comparison of graft-versus-host disease in children transplanted with HLA identical sibling umbilical cord blood versus HLA identical sibling bone marrow transplant. N Engl J Med 2000;342:1846-54.
33. Rocha V, Cornish J, Sievers E et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
34. Rocha V, Labopin M, Sanz G et al. The Acute Leukemia Working Party of European Blood and Marrow Transplant group and Eurocord-Netcord registry. Comparison of outcomes after unrelated umbilical cord versus unrelated bone marrow transplants in adults with acute leukemia. N Engl J Med 2004; 351:12-21.
35. Barker JN, Davies SM, DeFor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-61.
36. Garderet L, Dulphy N, Douay C et al. The umbilical cord blood αβ T cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998;91:340-6.
37. Talvensaari K, Clave E, Douay C et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002;99:1458-64.
38. Niehues T, Rocha V, Filipovich AH et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children: a Eurocord analysis. Br J Haematol 2001;114:42-8.
39. Rubinstein P, Rosenfield RD, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-90.
40. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92: 10119-22.
41. Wernet PW. The International Netcord Foundation in Cord Blood. Biology, Immunology, Banking and Clinical Transplantation. Bethesda, MD: AABB Press, 2004.
42. Gluckman E, Rocha V, Boyer Chammard A et al. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
43. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999;93:3662-7.
44. Michel G, Rocha V, Chevret S et al. For the Eurocord Group. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord group analysis. Blood 2003;102: 1-8.
45. Cairo MS, Wagner JE. Placental and/or umbilical cord blood an alternative source of haemopoietic stem cells for transplantation. Blood 1997;90:4665-78.
46. Kurtzberg J, Laughlin M, Graham L et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
47. Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA matched and HLA mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft versus host disease. Blood 1996;88:795-802.
48. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
49. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
50. Sanz GF, Saavedra S, Planelles D et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001;98:2332-8.
51. Ooi J, Iseki T, Takahashi S et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003;101:4711-3.
52. Ooi J, Iseki T, Takahashi S et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-91.
53. Gluckman E, Rocha V, Arcese W et al. On behalf of Eurocord group. Factors associated with outcome of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32: 397-407.
54. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100:1611-8.
55. Frassoni F, Podestà M, Maccario R et al. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 2003;102: 1138-41.
56. Migliaccio AM, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
57. Barker JN, Weisdorf DJ, DeFor TE et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003;102:1915-9.